Metropolitan Life Insurance Company (MetLife)’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-17,400
| Closed | -$160K | – | 2647 |
|
|
2017
Q1 | $160K | Buy |
+17,400
| New | +$160K | ﹤0.01% | 2381 |
|
|
2016
Q4 | – | Sell |
-14,742
| Closed | -$169K | – | 2697 |
|
|
2016
Q3 | $169K | Buy |
14,742
+581
| +4% | +$6.66K | ﹤0.01% | 2440 |
|
|
2016
Q2 | $174K | Sell |
14,161
-798
| -5% | -$9.81K | ﹤0.01% | 2420 |
|
|
2016
Q1 | $151K | Buy |
14,959
+90
| +0.6% | +$908 | ﹤0.01% | 2342 |
|
|
2015
Q4 | $335K | Buy |
14,869
+4,035
| +37% | +$90.9K | ﹤0.01% | 1896 |
|
|
2015
Q3 | $180K | Hold |
10,834
| – | – | ﹤0.01% | 2359 |
|
|
2015
Q2 | $244K | Buy |
10,834
+524
| +5% | +$11.8K | ﹤0.01% | 2266 |
|
|
2015
Q1 | $266K | Hold |
10,310
| – | – | ﹤0.01% | 1902 |
|
|
2014
Q4 | $224K | Hold |
10,310
| – | – | ﹤0.01% | 2338 |
|
|
2014
Q3 | $195K | Buy |
10,310
+40
| +0.4% | +$757 | ﹤0.01% | 2387 |
|
|
2014
Q2 | $239K | Buy |
+10,270
| New | +$239K | ﹤0.01% | 2384 |
|